PMID- 18635688 OWN - NLM STAT- MEDLINE DCOM- 20080819 LR - 20211020 IS - 1091-6490 (Electronic) IS - 0027-8424 (Print) IS - 0027-8424 (Linking) VI - 105 IP - 29 DP - 2008 Jul 22 TI - Foxp3+ natural regulatory T cells preferentially form aggregates on dendritic cells in vitro and actively inhibit their maturation. PG - 10113-8 LID - 10.1073/pnas.0711106105 [doi] AB - Naturally occurring CD4(+)CD25(+) regulatory T cells (Treg) suppress in vitro the proliferation of other T cells in a cell-contact-dependent manner. Dendritic cells (DCs) appear to be a target of Treg-mediated immune suppression. We show here that, in coculture of dye-labeled Treg cells and CD4(+)CD25(-) naive T cells in the presence of T cell receptor stimulation, Treg cells, which are more mobile than naive T cells in vitro, out-compete the latter in aggregating around DCs. Deficiency or blockade of leukocyte function-associated antigen-1 (LFA-1) (CD11a/CD18) abrogates Treg aggregation, whereas that of cytotoxic T lymphocyte-associated antigen 4 (CTLA-4) (CD152) does not. After forming aggregates, Treg cells specifically down-regulate the expression of CD80/86, but not CD40 or class II MHC, on DCs in both a CTLA-4- and LFA-1-dependent manner. Notably, Treg exerts this CD80/86-down-modulating effect even in the presence of strong DC-maturating stimuli, such as GM-CSF, TNF-alpha, IFN-gamma, type I IFN, and lipopolysaccharide. Taken together, as a possible mechanism of in vitro Treg-mediated cell contact-dependent suppression, we propose that antigen-activated Treg cells exert suppression by two distinct steps: initial LFA-1-dependent formation of Treg aggregates on immature DCs and subsequent LFA-1- and CTLA-4-dependent active down-modulation of CD80/86 expression on DCs. Both steps prevent antigen-reactive naive T cells from being activated by antigen-presenting DCs, resulting in specific immune suppression and tolerance. FAU - Onishi, Yasushi AU - Onishi Y AD - Department of Experimental Pathology, Institute for Frontier Medical Sciences, Kyoto University, Kyoto 606-8507, Japan. FAU - Fehervari, Zoltan AU - Fehervari Z FAU - Yamaguchi, Tomoyuki AU - Yamaguchi T FAU - Sakaguchi, Shimon AU - Sakaguchi S LA - eng PT - Journal Article PT - Research Support, Non-U.S. Gov't DEP - 20080717 PL - United States TA - Proc Natl Acad Sci U S A JT - Proceedings of the National Academy of Sciences of the United States of America JID - 7505876 RN - 0 (Antigens, CD) RN - 0 (B7-1 Antigen) RN - 0 (B7-2 Antigen) RN - 0 (CTLA-4 Antigen) RN - 0 (Cd86 protein, mouse) RN - 0 (Ctla4 protein, mouse) RN - 0 (Forkhead Transcription Factors) RN - 0 (Foxp3 protein, mouse) RN - 0 (Lymphocyte Function-Associated Antigen-1) RN - 0 (Receptors, Antigen, T-Cell) RN - 9006-59-1 (Ovalbumin) SB - IM MH - Animals MH - Antigens, CD/genetics/immunology/metabolism MH - B7-1 Antigen/metabolism MH - B7-2 Antigen/metabolism MH - CTLA-4 Antigen MH - Cell Aggregation MH - Cell Differentiation MH - Dendritic Cells/*cytology/*immunology/metabolism MH - Female MH - Forkhead Transcription Factors/*metabolism MH - Lymphocyte Function-Associated Antigen-1/genetics/immunology/metabolism MH - Mice MH - Mice, Inbred BALB C MH - Mice, Inbred C57BL MH - Mice, Knockout MH - Mice, Transgenic MH - Models, Immunological MH - Ovalbumin/genetics/immunology MH - Receptors, Antigen, T-Cell/genetics/metabolism MH - T-Lymphocytes, Regulatory/*cytology/*immunology/metabolism PMC - PMC2481354 COIS- The authors declare no conflict of interest. EDAT- 2008/07/19 09:00 MHDA- 2008/08/20 09:00 PMCR- 2009/01/22 CRDT- 2008/07/19 09:00 PHST- 2008/07/19 09:00 [pubmed] PHST- 2008/08/20 09:00 [medline] PHST- 2008/07/19 09:00 [entrez] PHST- 2009/01/22 00:00 [pmc-release] AID - 0711106105 [pii] AID - 3476 [pii] AID - 10.1073/pnas.0711106105 [doi] PST - ppublish SO - Proc Natl Acad Sci U S A. 2008 Jul 22;105(29):10113-8. doi: 10.1073/pnas.0711106105. Epub 2008 Jul 17.